 |
인쇄하기
취소
|
Court rules fine over ‘pay for delay’ to GSK is justifiable
An appeals court ruled Thursday that fines of 3.1 billion won was justifiable over “pay for delay” the Fair Trade Commission (FTC) imposed to GlaxoSmithKline (GSK).
Turning down an appeal from GSK, the Seoul High Court said that the agreement on Zofran (ondansetron) executed between Dong-A Pharma and GSK was illegal as GSK proved to have paid Dong-A, provided that the latter should not intro...
Turning down an appeal from GSK, the Seoul High Court said that the agreement on Zofran (ondansetron) executed between Dong-A Pharma and GSK was illegal as GSK proved to have paid Dong-A, provided that the latter should not intro...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.